Abstract
The Chagas Disease is still a global threat, with an estimated 6 to 7 million people infected, mainly in Latin America. Despite the efforts of national and international agencies to develop an innovative strategy against this disease, no drug candidate has met all the necessary requirements for clinical use. In Brazil, the benznidazole drug is the only drug available for the treatment, an…